Chemoinformaics analysis of 1-{3-[(3,5-DICHLOROBENZYL)AMINO]PROPYL}-3-PHENYLUREA
| Molecular Weight | 352.265 | nRot | 7 |
| Heavy Atom Molecular Weight | 333.113 | nRig | 13 |
| Exact Molecular Weight | 351.091 | nRing | 2 |
| Solubility: LogS | -3.993 | nHRing | 0 |
| Solubility: LogP | 3.661 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 49.5211 |
| nHD | 3 | BPOL | 22.6589 |
| QED | 0.651 |
| Synth | 1.877 |
| Natural Product Likeliness | -1.641 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.287 |
| Pgp-sub | 0.975 |
| HIA | 0.068 |
| CACO-2 | -5.115 |
| MDCK | 0.000064 |
| BBB | 0.839 |
| PPB | 0.873778 |
| VDSS | 2.101 |
| FU | 0.0784031 |
| CYP1A2-inh | 0.898 |
| CYP1A2-sub | 0.882 |
| CYP2c19-inh | 0.783 |
| CYP2c19-sub | 0.784 |
| CYP2c9-inh | 0.075 |
| CYP2c9-sub | 0.352 |
| CYP2d6-inh | 0.982 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.455 |
| CYP3a4-sub | 0.319 |
| CL | 8.258 |
| T12 | 0.341 |
| hERG | 0.721 |
| Ames | 0.011 |
| ROA | 0.598 |
| SkinSen | 0.431 |
| Carcinogencity | 0.03 |
| EI | 0.011 |
| Respiratory | 0.254 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.606612 |